As of 2025-05-18, the EV/EBITDA ratio of Insmed Inc (INSM) is -15.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 13,113.72 mil USD. INSM's TTM EBITDA according to its financial statements is -841.27 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.7x | 13.4x |
| Forward P/E multiples | 12.4x - 14.4x | 13.3x |
| Fair Price | (61.29) - (67.21) | (65.77) |
| Upside | -190.0% - -198.7% | -196.6% |
| Date | EV/EBITDA |
| 2025-05-16 | -15.59 |
| 2025-05-15 | -15.39 |
| 2025-05-14 | -15.05 |
| 2025-05-13 | -15.07 |
| 2025-05-12 | -15.51 |
| 2025-05-09 | -14.93 |
| 2025-05-08 | -15.05 |
| 2025-05-07 | -15.62 |
| 2025-05-06 | -15.53 |
| 2025-05-05 | -16.55 |
| 2025-05-02 | -16.49 |
| 2025-05-01 | -16.56 |
| 2025-04-30 | -16.43 |
| 2025-04-29 | -16.30 |
| 2025-04-28 | -15.96 |
| 2025-04-25 | -15.93 |
| 2025-04-24 | -15.77 |
| 2025-04-23 | -16.17 |
| 2025-04-22 | -16.26 |
| 2025-04-21 | -15.89 |
| 2025-04-17 | -16.57 |
| 2025-04-16 | -16.04 |
| 2025-04-15 | -16.23 |
| 2025-04-14 | -16.22 |
| 2025-04-11 | -15.69 |
| 2025-04-10 | -14.87 |
| 2025-04-09 | -15.46 |
| 2025-04-08 | -14.91 |
| 2025-04-07 | -15.58 |
| 2025-04-04 | -15.82 |
| 2025-04-03 | -16.71 |
| 2025-04-02 | -16.74 |
| 2025-04-01 | -16.43 |
| 2025-03-31 | -17.35 |
| 2025-03-28 | -17.72 |
| 2025-03-27 | -17.66 |
| 2025-03-26 | -17.41 |
| 2025-03-25 | -17.84 |
| 2025-03-24 | -18.02 |
| 2025-03-21 | -18.14 |
| 2025-03-20 | -17.89 |
| 2025-03-19 | -17.93 |
| 2025-03-18 | -17.51 |
| 2025-03-17 | -17.67 |
| 2025-03-14 | -17.41 |
| 2025-03-13 | -17.09 |
| 2025-03-12 | -16.87 |
| 2025-03-11 | -16.79 |
| 2025-03-10 | -16.66 |
| 2025-03-07 | -17.05 |